More on HAE
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $108.40 |
|
|||
| Open | $108.40 | ||||
| 52 Wk High | $39.41 | ||||
| 52 Wk Low | $25.98 | ||||
| Day High | $108.40 | ||||
| Day Low | $108.40 | ||||
| P/E | 152.68 | ||||
| EPS | $0.71 | ||||
| Volume | 91 | ||||
- Haemonetics (HAE) spreader of 500 contracts of November 115 and 130 calls as share price up 2.5%
- Citi upgrades Haemonetics to Buy, raises price target to $123
- Orchestra BioMed receives $6.1M milestone payment from Vivasure deal
- Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
- Azenta names board member as interim CEO after Marotta resigns
- AZENTA ANNOUNCES LEADERSHIP TRANSITION
- Haemonetics (HAE) PT Raised to $119 at Baird
- Haemonetics signs non-exclusive supply deal with CSL Plasma
- Form 8-K HAEMONETICS CORP For: Aug 18
- Form SCHEDULE 13G/A HAEMONETICS CORP Filed by: AQR CAPITAL MANAGEMENT LLC
Entities mentioned with HAE
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Trading Radar | View Related Stories »
- Show More...
